This NIHR programme grant has developed and tested a mobile-device based system delivering automated, tailored brief messages to offer support for medicine use alongside usual care to people with type 2 diabetes. This included developing and refining the content of messages targeted at a wide range of medication adherence behaviours, and developing and optimising the system for delivering them. The new automated message system is now the focus of a randomised controlled trial.
Contacts
- Louise Locock; louise.locock@abdn.ac.uk
Status
CompletedPublications
The SuMMiT-D Collaborative Group, Farmer, AJ, Allen, J, Bartlett, YK, Bower, P, Chi, Y, French, DP, Gudgin, B, Holmes, E, Horne, R, Hughes, DA, Jones, L, Kenning, C, Locock, L, McSharry, J, Miles, L, Newhouse, N, Rea, R, Robinson, S, Tarassenko, L, Velardo, C, Williams, N & Yu, LM 2024, 'Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial', Pilot and Feasibility Studies, vol. 10, 15.
Farmer A, Jones L, Newhouse N, Kenning C, William, N, Chi Y, Bartlett YK, Plumpton C, McSharry J, Cholerton R, Holmes E, Robinson S, Allen J, Gudgin B, Velardo C, Rutter H, Horne R, Tarassenko L, Williams V, Locock L, Rea R, Yu LM, Hughes D, Bower P, French D. , JMIR Research Protocols, vol. 11, no. 2, e32918. 2022 https://doi.org/10.2196/32918
Bartlett K, Kenning C, Crosland J, Newhouse N, Miles LM, Williams V, McSharry J, Locock L, Farmer AJ, French D. BMC Health Services Research, vol. 21, no. 1, 608. 2021 https://doi.org/10.1186/s12913-021-06663-2
SuMMiT-D Collaborative Group 2019, , BMJ Open, vol. 9, no. 12, e033504. https://doi.org/10.1136/bmjopen-2019-033504